Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The ready-to-administer tablet format speeds up study setup, ensures every subject or culture receives the exact same peptide amount, and mirrors potential oral-delivery routeshelping bridge in vitro findings with in vivo models
The product is intended for laboratory use, comparative analyses and reference procedures only
The glucagon-like peptide-1 receptor (GLP-1R) is a key target for diabetes mellitus (DM) treatment, and GLP-1R agonists are pharmaceutical compounds employed in the treatment of DM
The N-terminal ECD of the GLP1R protein can form a three-layer -- fold stabilized by three pairs of disulfide bonds between cysteine residues
It may also include kojic acid, azelaic acid, and antioxidant protection in the form of resveratrol and green tea extract to supplement the effects of hydroquinone
